Philips Launches SmartIQ to Reduce Radiation-Image Quality Trade-Off in Coronary Interventions
SHERIDAN, WYOMING - May 19, 2026 - Royal Philips has introduced SmartIQ, a new coronary imaging technology integrated into its Azurion image-guided therapy platform, designed to address a long-standing clinical challenge in interventional cardiology: balancing high image quality with reduced radiation exposure. The system was developed with cardiovascular centers and focuses on ultra-low dose imaging protocols that maintain diagnostic clarity while lowering X-ray exposure for patients and clinical staff. Philips is positioning the technology as part of a broader strategy to strengthen workflow consistency, evidence generation, and dose optimization in coronary procedures, with initial clinical validation already underway through published pilot studies and ongoing multicenter research programs.